BAMBI (bone morphogenetic protein and activin membrane-bound inhibitor) reveals the involvement of the transforming growth factor-β family in pain modulation

Journal of Neuroscience

Volumn 30, Issue 4, 2010, Pages 1502-1511

  Tramullas, Mónica ^a,b   Lantero, Aquilino ^a,b   Díaz, Álvaro ^a,c,d   Morchón, Néstor ^a   Merino, David ^a,b   Villar, Ana ^a,b   Buscher, Dirk ^f,g   Merino, Ramón ^a,b,c   Hurlé, Juan M ^a,b   Izpisúa Belmonte, Juan Carlos ^e,f   Hurlé, María A ^a,b  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^c University of Cantabria   (Spain)

^d CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^e Centre de Medicina Regenerativa de Barcelona   (Spain)

^f SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^g CELLERIX GENETRIX Tres Cantos   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN AND ACTIVIN MEMBRANE BOUND INHIBITOR; DELTA OPIATE RECEPTOR; MESSENGER RNA; NALOXONE; OSTEOGENIC PROTEIN 1; PRODYNORPHIN; PROENKEPHALIN; PROOPIOMELANOCORTIN; PROTEIN INHIBITOR; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION; GENETIC CODE; HYPOALGESIA; INFLAMMATION; MALE; MECHANICAL STIMULATION; MOUSE; NERVE INJURY; NEUROPATHIC PAIN; NOCICEPTION; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPINAL CORD; STIMULATION; THERMAL STIMULATION; TRANSCRIPTION REGULATION;

ACTIVINS; AFFERENT PATHWAYS; ANIMALS; BONE MORPHOGENETIC PROTEIN 7; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENKEPHALINS; HYPERALGESIA; MALE; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; NARCOTIC ANTAGONISTS; NOCICEPTORS; PAIN MEASUREMENT; PAIN THRESHOLD; PERIPHERAL NERVES; PERIPHERAL NERVOUS SYSTEM DISEASES; PRO-OPIOMELANOCORTIN; PROTEIN PRECURSORS; RECEPTORS, OPIOID, DELTA; SCIATIC NEUROPATHY; SIGNAL TRANSDUCTION; SPINAL CORD; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 75349097160     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2584-09.2010     Document Type: Article

References (63)

1. Ageta H, Murayama A, Migishima R, Kida S, Tsuchida K, Yokoyama M, Inokuchi K (2008) Activin in the brain modulates anxiety-related behavior and adult neurogenesis. PLoS ONE 3:e1869.
2. Bester H, Beggs S, Woolf CJ (2000) Changes in tactile stimuli-induced behavior and c-Fos expression in the superficial dorsal horn and in parabrachial nuclei after sciatic nerve crush. J Comp Neurol 428:45- 61.
3. Böttner M, Krieglstein K, Unsicker K (2000) The transforming growth factor-βs: structure, signalling, and roles in nervous system development and functions. J Neurochem 75:2227-2240.
4. Bouret S, Chuoi-Mariot MT, Prevot V, Croix D, Takumi T, Jegou S, Vaudry H, Beauvillain JC, Mitchell V (2001) Evidence that TGF beta may directly modulate POMC mRNA expression in the female rat arcuate nucleus. Endocrinology 142:4055- 4065.
5. Bourquin AF, Süveges M, Pertin M, Gilliard N, Sardy S, Davison AC, Spahn DR, Decosterd I (2006) Assessment and analysis of mechanical allodynia-like behavior induced by spared nerve injury (SNI) in the mouse. Pain 122:14.e1-14.
6. Brionne TC, Tesseur I, Masliah E, Wyss-Coray T (2003) Loss of TGF-beta 1 leads to increased neuronal cell death and microgliosis in mouse brain. Neuron 40:1133-1145.
7. Chen HL, Lein PJ, Wang JY, Gash D, Hoffer BJ, Chiang YH (2003) Expression of bone morphogenetic proteins in the brain during normal aging and in 6-hydroxydopamine-lesioned animals. Brain Res 994:81-90.
8. Chen J, Bush JO, Ovitt CE, Lan Y, Jiang R (2007) The TGF-beta pseudoreceptor gene Bambi is dispensable for mouse embryonic development and postnatal survival. Genesis 45:482- 486.
9. Coderre TJ, Vaccarino AL, Melzack R (1990) Central nervous system plasticity in the tonic pain response to subcutaneous formalin injection. Brain Res 535:155-158.
10. Decosterd I, Woolf CJ (2000) Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain 87:149 -158.
11. De Sousa BN, Horrocks LA (1979) Development of rat spinal cord. I. Weight and length with a method for rapid removal. Dev Neurosci 2:115-121.
12. Dhawan BN, Cesselin F, Raghubir R, Reisine T, Bradley PB, Portoghese PS, Hamon M (1996) International Union of Pharmacology. XII. Classification of opioid receptors. Pharmacol Rev 48:567-592.
13. Echeverry S, Shi XQ, Haw A, Liu H, Zhang ZW, Zhang J (2009) Transforming growth factor-beta1 impairs neuropathic pain through pleiotropic effects. Mol Pain 5:16.
14. Fan X, Xu H, Cai W, Yang Z, Zhang J (2003) Spatial and temporal patterns of expression of Noggin and BMP4 in embryonic and postnatal rat hippocampus. Brain Res Dev Brain Res 146:51-58.
15. Feng XH, Derynck R (2005) Secificity and versatility in TGF-β signaling through smads. Annu Rev Cell Dev Biol 21:659-693.
16. Fields HL (2000) Pain modulation: expectation, opioid analgesia and virtual pain. Prog Brain Res 122:245-253.
17. Fritzmann J, Morkel M, Besser D, Budczies J, Kosel F, Brembeck FH, Stein U, Fichtner I, Schlag PM, Birchmeier W (2009) A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential. Gastroenterology 137:165-175.
18. Funaba M, Murata T, Fujimura H, Murata E, Abe M, Torii K (1997) Immunolocalization of type I or type II activin receptors in the rat brain. J Neuroendocrinol 9:105-111.
19. Gerlai R (1996) Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype? Trends Neurosci 19:177-181.
20. Grotewold L, Plum M, Dildrop R, Peters T, Rüther U (2001) Bambi is coexpressed with Bmp-4 during mouse embryogenesis. Mech Dev 100:327-330.
21. Guan Y, Borzan J, Meyer RA, Raja SN (2006) Windup in dorsal horn neurons is modulated by endogenous spinal μ-opioid mechanisms. J Neurosci 26:4298-4307.
22. Hao JX, Yu W, Xu XJ (1998) Evidence that spinal endogenous opioidergic systems control the expression of chronic pain-related behaviors in spinally injured rats. Exp Brain Res 118:259 -268.
23. Hao S, Mata M, Goins W, Glorioso JC, Fink DJ (2003) Transgene-mediated enkephalin release enhances the effect of morphine and evades tolerance to produce a sustained antiallodynic effect in neuropathic pain. Pain 102:135-142.
24. Harada K, Sato Y, Ikeda H, Isse K, Ozaki S, Enomae M, Ohama K, Katayanagi K, Kurumaya H, Matsui A, Nakanuma Y (2009) Epithelial-mesenchymal transition induced by biliary innate immunity contributes to the sclerosing cholangiopathy of biliary atresia. J Pathol 217:654-664.
25. Israelsson C, Lewén A, Kylberg A, Usoskin D, Althini S, Lindeberg J, Deng CX, Fukuda T, Wang Y, Kaartinen V, Mishina Y, Hillered L, Ebendal T (2006) Genetically modified bone morphogenetic protein signalling alters traumatic brain injury-induced gene expression responses in the adult mouse. J Neurosci Res 84:47-57.
26. Kamphuis S, Kavelaars A, Brooimans R, Kuis W, Zegers BJ, Heijnen CJ (1997) T helper 2 cytokines induce preproenkephalin mRNA expression and proenkephalin A in human peripheral blood mononuclear cells. J Neuroimmunol 79:91-99.
27. Karaulanov E, Knöchel W, Niehrs C (2004) Transcriptional regulation of BMP4 synexpression in transgenic Xenopus. EMBO J 23:844-856.
28. Kavelaars A, Heijnen CJ (2000) Expression of preproenkephalin mRNA and production and secretion of enkephalins by human thymocytes. Ann NY Acad Sci 917:778 -783.
29. Khin SS, Kitazawa R, Win N, Aye TT, Mori K, Kondo T, Kitazawa S (2009) BAMBI gene is epigenetically silenced in subset of high-grade bladder cancer. Int J Cancer 125:328 -338.
30. Kitazawa S, Kitazawa R, Obayashi C, Yamamoto T (2005) Desmoid tumor with ossification in chest wall: possible involvement of BAMBI promoter hypermethylation in metaplastic bone formation. J Bone Miner Res 20:1472-1477.
31. Kondo I, Marvizon JC, Song B, Salgado F, Codeluppi S, Hua XY, Yaksh TL (2005) Inhibition by spinal mu- and delta-opioid agonists of afferent-evoked substance P release. J Neurosci 25:3651-3660.
32. König M, Zimmer AM, Steiner H, Holmes PV, Crawley JN, Brownstein MJ, Zimmer A (1996) Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin. Nature 383:535-538.
33. Lin Z, Gao C, Ning Y, He X, Wu W, Chen YG (2008) The pseudoreceptor BMP and activin membrane-bound inhibitor positively modulates Wnt/beta-catenin signaling. J Biol Chem 283:33053-33058.
34. Mansikka H, Zhao C, Sheth RN, Sora I, Uhl G, Raja SN (2004) Nerve injury induces a tonic bilateral mu-opioid receptor-mediated inhibitory effect on mechanical allodynia in mice. Anesthesiology 100:912-921.
35. Martínez-Cué C, Rueda N, García E, Davisson MT, Schmidt C, Fló rez J (2005) Behavioral, cognitive and biochemical responses to different environmental conditions in male Ts65Dn mice, a model of Down syndrome. Behav Brain Res 163:174 -185.
36. Massagué J, Seoane J, Wotton D (2005) Smad transcription factors. Genes Dev 19:2783-2810.
37. McNamara CR, Mandel-Brehm J, Bautista DM, Siemens J, Deranian KL, Zhao M, Hayward NJ, Chong JA, Julius D, Moran MM, Fanger CM (2007) TRPA1 mediates formalin-induced pain. Proc Natl Acad Sci U S A 104:13525-13530.
38. Mehler MF, Mabie PC, Zhang D, Kessler JA (1997) Bone morphogenetic proteins in the nervous system. Trends Neurosci 20:309 -317.
39. Mikawa S, Wang C, Sato K (2006) Bone morphogenetic protein-4 expression in the adult rat brain. J Comp Neurol 499:613- 625.
40. Nudi M, Ouimette JF, Drouin J (2005) Bone morphogenic protein (Smad)-mediated repression of proopiomelanocortin transcription by interference with Pitx/Tpit activity. Mol Endocrinol 19:1329 -1342.
41. Onichtchouk D, Chen YG, Dosch R, Gawantka V, Delius H, Massagué J, Niehrs C (1999) Silencing of TGF-beta signalling by the pseudoreceptor BAMBI. Nature 401:480-485.
42. Pasternak GW (2005) Molecular biology of opioid analgesia. J Pain Symptom Manage 29:S2-S9.
43. Pena E, Berciano MT, Fernandez R, Ojeda JL, Lafarga M (2001) Neuronal body size correlates with the number of nucleoli and Cajal bodies, and with the organization of splicing machinery in rat trigeminal ganglion neurons. J Comp Neurol 430:250 -263.
44. Rubinstein M, Mogil JS, Japón M, Chan EC, Allen RG, Low MJ (1996) Absence of opioid stress-induced analgesia in mice lacking β-endorphin by site-directed mutagenesis. Proc Natl Acad Sci U S A 93:3995- 4000.
45. Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, Brenner DA, Schwabe RF (2007) TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 13:1324 -1332.
46. Tjølsen A, Berge OG, Hunskaar S, Rosland JH, Hole K (1992) The formalin test: an evaluation of the method. Pain 51:5-17.
47. Todd AJ, Koerber R (2006) Neuroanatomical substrates of spinal nociception. In: Wall and Melzack's textbook of pain, Ed 5 (McMahon SB, Koltzenburg M, eds), pp 73-90. London: Elsevier.
48. Togo N, Ohwada S, Sakurai S, Toya H, Sakamoto I, Yamada T, Nakano T, Muroya K, Takeyoshi I, Nakajima T, Sekiya T, Yamazumi Y, Nakamura T, Akiyama T (2008) Prognostic significance of BMP and activin membrane-bound inhibitor in colorectal cancer. World J Gastroenterol 14:4880-4888.
49. Tsang M, Kim R, de Caestecker MP, Kudoh T, Roberts AB, Dawid IB (2000) Zebrafish nma is involved in TGFbeta family signaling. Genesis 28:47-57.
50. Tsou K, Khachaturian H, Akil H, Watson SJ (1986) Immunocytochemical localization of pro-opiomelanocortin-derived peptides in adult rat spinal cord. Brain Res 378:28 -35.
51. Unsicker K, Strelau J (2000) Functions of transforming growth factor-beta isoforms in the nervous system. Cues based on localization and experimental in vitro and in vivo evidence. Eur J Biochem 267:6972- 6975.
52. Vierck Jr CJ (2006) Animal models of pain. In: Wall and Melzack's textbook of pain, Ed 5 (McMahon SB, Koltzenburg M), pp 175-186. London: Elsevier.
53. Vivien D, Ali C (2006) Transforming growth factor-beta signalling in brain disorders. Cytokine Growth Factor Rev 17:121-128.
54. Wrana JL, Attisano L, Wieser R, Ventura F, Massagué J (1994) Mechanism of activation of the TGF-beta receptor. Nature 370:341-347.
55. Wu CM, Lin MW, Cheng JT, Wang YM, Huang YW, Sun WZ, Lin CR (2004) Regulated, electroporation-mediated delivery of pro-opiomelanocortin gene suppresses chronic constriction injury-induced neuropathic pain in rats. Gene Ther 11:933-940.
56. Xu P, Van Slambrouck C, Berti-Mattera L, Hall AK (2005) Activin induces tactile allodynia and increases calcitonin gene-related peptide after peripheral inflammation. J Neurosci 25:9227-9235.
57. Yaksh TL, Gross KE, Li CH (1982) Studies on the intrathecal effect of beta-endorphin in primate. Brain Res 241:261-269.
58. Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, Ueno N, Taniguchi T, Nishida E, Matsumoto K (1995) Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction. Science 270:2008 -2011.
59. Yan X, Lin Z, Chen F, Zhao X, Chen H, Ning Y, Chen YG (2009) Human BAMBI cooperates with Smad7 to inhibit TGF-β signaling. J Biol Chem 284:30097-30104.
60. Zhang YE (2009) Non-Smad pathways in TGF-beta signaling. Cell Res 19:128 -139.
61. Zhu W, Xu P, Cuascut FX, Hall AK, Oxford GS (2007) Activin acutely sensitizes dorsal root ganglion neurons and induces hyperalgesia via PKC-mediated potentiation of transient receptor potential vanilloid I. J Neurosci 27:13770-13780.
62. Zimmermann M (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16:109 -110.
63. Zuzarte-Luís V, Montero JA, Rodriguez-León J, Merino R, Rodríguez-Rey JC, Hurlé JM (2004) A new role for BMP5 during limb development acting through the synergic activation of Smad and MAPK pathways. Dev Biol 272:39-52.